| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000Ma 4500 |
| 001 |
in00003544921 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
130418s1999 gw a ob 001 0 eng d |
| 005 |
20260422204350.7 |
| 020 |
|
|
|a 9783662037874 (electronic bk.)
|
| 020 |
|
|
|a 3662037874 (electronic bk.)
|
| 020 |
|
|
|z 9783662037898
|
| 024 |
7 |
|
|a 10.1007/978-3-662-03787-4
|2 doi
|
| 035 |
|
|
|a (OCoLC)864227321
|
| 040 |
|
|
|a SINTU
|b eng
|c SINTU
|d OCLCO
|d GW5XE
|d UtOrBLW
|
| 049 |
|
|
|a TXAM
|
| 050 |
|
4 |
|a QR187.5
|b .I57194 1999eb
|
| 072 |
|
7 |
|a MMG
|2 bicssc
|
| 072 |
|
7 |
|a MED071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.07/91
|2 23
|
| 082 |
0 |
4 |
|a 615
|2 23
|
| 245 |
0 |
0 |
|a Interferon :
|b the dawn of recombinant protein drugs /
|c J. Lindenmann, W.-D. Schleuning, editors.
|
| 264 |
|
1 |
|a Berlin ;
|a New York :
|b Springer,
|c [1999]
|
| 264 |
|
4 |
|c ©1999
|
| 300 |
|
|
|a 1 online resource (xiv, 136 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Ernst Schering Research Foundation workshop. Supplement,
|x 0947-6075 ;
|v 5
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 520 |
|
|
|a This book describes the discovery, the production and the clinical development of interferon, one of the first genetically engineered proteins and one of the most innovative and successful drugs of all time. The authors all played either a key role in this process or are highly reputed historians of science. This volume is a must for everyone who appreciates the enormous cultural and social implications of scientific endeavor.
|
| 505 |
0 |
|
|a Is there life without interferon? / N.B. Finter -- The prehistory and history of the uses of interleukin-2 in cancer therapy / T. Pieters -- Interferon-alpha: from pass interference to cytokine networking / I. Löwy -- A biosemiotic view of interferon: toward a biology of really living organisms / P. Fitzgerald-Bocarsly -- The clinical and social impact of beta interferon: the first approved therapy in multiple sclerosis / Y. Kawade -- Closing discussion / McFarland.
|
| 500 |
|
|
|a Electronic resource.
|
| 650 |
|
0 |
|a Interferon
|x History.
|
| 650 |
1 |
2 |
|a Interferons
|x history
|v Congresses.
|
| 650 |
2 |
2 |
|a Interferons
|x therapeutic use
|v Congresses.
|
| 650 |
1 |
7 |
|a Interferonen.
|2 gtt
|
| 650 |
0 |
7 |
|a Interferon.
|2 swd
|
| 650 |
|
7 |
|a Interferon.
|2 fast
|0 (OCoLC)fst00976239
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 655 |
|
7 |
|a History.
|2 fast
|0 (OCoLC)fst01411628
|
| 700 |
1 |
|
|a Lindenmann, Jean.
|
| 700 |
1 |
|
|a Schleuning, Wolf-Dieter,
|d 1944-
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 776 |
1 |
8 |
|i Printed edition:
|z 9783662037898
|
| 830 |
|
0 |
|a Ernst Schering Research Foundation workshop.
|p Supplement ;
|v 5.
|x 0947-6075
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://link.springer.com/10.1007/978-3-662-03787-4
|z Connect to the full text of this electronic book
|t 0
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 22efdbae-b98d-32f7-8f38-c6b46c7f5bf8
|i a0dffe8f-fb64-36dc-a27f-46013d402644
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s www_evans
|d Available Online
|t 0
|e QR187.5 .I57194 1999eb
|h Library of Congress classification
|
| 998 |
f |
f |
|a QR187.5 .I57194 1999eb
|t 0
|l Available Online
|